Call for abstracts - Immunotherapy bridge 2017


Immunotherapy Bridge Presidents are glad to invite the submission of abstracts for the presentation of oral communications and posters at next meeting held in Naples (Italy) from November 29th to November 30th

The themes of oral and poster presentation are:

  • System biology: immunology
  • Immunotherapy beyond melanoma
  • Evolving topics in cancer immunotherapy (SITC)
  • Immunotherapy in oncology: data from clinical trials
Attendees are expected from all around the world and encouraged to submit their abstracts for poster or oral presentation during the event. The speaker of the abstracts selected for oral communication will be exempt from registration fee and invited as speakers to Naples.

Important Dates for Abstracts Submission:

Submission opening: June 23th, 2017
Submission deadline: September 24th, 2017

Notification: October 3rd, 2017

Late breaking abstract will not be accepted

Submission Guidelines

Submit your abstract as word file by e-mail to abstract@melanomabridge.org

Receipt of your abstract will be acknowledged by e-mail within a few days. If acknowledgement is not received within one week of submission, please contact us again.

Please find an example abstract here

Proposed session

Title
The title should be in bold, sentence case with no full stop at the end and no underlining

Authors
First name, middle initials if required, and surname with no full stop at the end. Underline the name of the corresponding author. A comma should separate author names. Where authors are from different institutions, the appropriate institution number from the affiliation list should be given as a superscript number immediately after each author's name.

Affiliations
Affiliations should include department, institute, town and country. Where there are multiple affiliations, each should be listed as a separate paragraph. Each institute should appear in the order used against the author names (see above paragraph) and show the appropriate superscript number.

Main text
  • Should not be more than 400 words
  • Please use single line spacing
  • Type the text unjustified, without hyphenating words at line breaks
  • Structure the abstracts with paragraph headings typed in bold with no colon at the end
    • Background
    • Materials and methods
    • Results
    • Conclusions
Trial registration
The Journal of Translational Medicine supports prospective registration of randomized controlled clinical trials. Abstracts related to RCTs should include the trial registry along with the unique identifying number. Trial registers that currently meet our requirements can be found at this link.

References
All references should be cited/called out consecutively in the text, using numbers in square brackets. Only papers that have been published, or are in press, or are available through public e-print/preprint servers should be included in the reference list.
Journal abbreviations should follow MEDLINE standards.
References should be laid out at the end of the abstract and preceded by the relevant reference number.




For information please contact abstract@melanomabridge.org